Fentanyl: Difference between revisions
Elcatracho (talk | contribs) |
Elcatracho (talk | contribs) |
||
| Line 7: | Line 7: | ||
*Analgesia: 1-2 mcg/kg IV/IM, q30-60 min PRN | *Analgesia: 1-2 mcg/kg IV/IM, q30-60 min PRN | ||
*Sedation: 1-3 mcg/kg/hr continuous infusion | *Sedation: 1-3 mcg/kg/hr continuous infusion | ||
*Dosing based off total body weight | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Latest revision as of 09:23, 3 January 2022
General
- Type: Opioids
- Dosage Forms: IV, intranasal, transdermal
- Common Trade Names: Sublimaze
Adult Dosing
- Analgesia: 1-2 mcg/kg IV/IM, q30-60 min PRN
- Sedation: 1-3 mcg/kg/hr continuous infusion
- Dosing based off total body weight
Pediatric Dosing
- 0.5-2 mcg/kg IV/IN q1-2 hr
Special Populations[1]
- Pregnancy Rating: C
- Lactation: Excreted in breast milk, not recommended
- Renal Dosing
- Adult
- Not defined
- Pediatric
- Not defined but recommendations for IV:
- GFR > 50 mL/minute/1.73 m²: no adjustment
- GFR 10 to 50 mL/minute/1.73 m²: 75% of usual dose
- GFR < 10 mL/minute/1.73 m²: 50% of usual dose
- Hemodialysis: 50% of usual dose
- Not defined but recommendations for IV:
- Adult
- Hepatic Dosing
- Adult
- Not defined
- Pediatric
- Not defined
- Adult
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Apnea
Common
- Confusion
- Constipation
- Nausea/Vomiting
- Somnolence
- Sweating
- Asthenia
Pharmacology
- Half-life: 2-4 hours
- Metabolism: Hepatic
- Excretion: Renal
- Mechanism of Action: Narcotic opiate receptor agonist
See Also
References
- ↑ Fentanyl: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.
